Why the study?
Mitochondrial creatine kinase is down-regulated in chronic heart failure and may contribute to disease progression, leading researchers to test if its cardiomyocyte-specific overexpression would preserve cardiac function.
Does cardiomyocyte-specific overexpression of Mt-CK preserve cardiac function and energetics in a murine model of pressure overload-induced chronic heart failure?
Does cardiomyocyte-specific overexpression of Mt-CK preserve cardiac function and energetics in a murine model of pressure overload-induced chronic heart failure?
Overexpression of Mt-CK in mice preserves cardiac energetics during pressure overload but does not prevent the development of chronic heart failure or improve LV function.
Answers are grounded in this paper and cite their sources.
Preserves energetics without improving function or remodeling in pressure-overload mice; leaves open therapeutic translation of Mt-CK overexpression.
Mitochondrial creatine kinase (Mt-CK) is a major determinant of cardiac energetic status and is down-regulated in chronic heart failure, which may contribute to disease progression. We hypothesised that cardiomyocyte-specific overexpression of Mt-CK would mitigate against these changes and thereby preserve cardiac function. Male Mt-CK overexpressing mice (OE) and WT littermates were subjected to transverse aortic constriction (TAC) or sham surgery and assessed by echocardiography at 0, 3 and 6 weeks alongside a final LV haemodynamic assessment. Regardless of genotype, TAC mice developed progressive LV hypertrophy, dilatation and contractile dysfunction commensurate with pressure overload-induced chronic heart failure. There was a trend for improved survival in OE-TAC mice (90% vs 73%, P = 0.08), however, OE-TAC mice exhibited greater LV dilatation compared to WT and no functional parameters were significantly different under baseline conditions or during dobutamine stress test. CK activity was 37% higher in OE-sham versus WT-sham hearts and reduced in both TAC groups, but was maintained above normal values in the OE-TAC hearts. A separate cohort of mice received in vivo cardiac 31 P-MRS to measure high-energy phosphates. There was no difference in the ratio of phosphocreatine-to-ATP in the sham mice, however, PCr/ATP was reduced in WT-TAC but preserved in OE-TAC (1.04 ± 0.10 vs 2.04 ± 0.22; P = 0.007). In conclusion, overexpression of Mt-CK activity prevented the changes in cardiac energetics that are considered hallmarks of a failing heart. This had a positive effect on early survival but was not associated with improved LV remodelling or function during the development of chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: